INSPECS Group (SPEC) Share Price, News & Analysis

Company Overview

Inspecs is a designer, manufacturer and distributor of eyewear frames. The Group produces a broad range of frames, covering optical, sunglasses and safety, which are either “Branded” (either under licence or under the Group’s own proprietary brands), or “OEM” (including private label on behalf of retail customers and un-branded). As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market. Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 30,000 points of sale. In FY19, the Group generated 24.9 per cent. of its revenue in the UK and 75.1 per cent. internationally. Today Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, London and more recently, Italy. The Group’s growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group’s internal capabilities); and (iii) extend the Group’s manufacturing capacity. More information is available at: https://inspecs.com

Key Stats

• Today's Range: 39.04 to 41.80
• 50-Day Range: 40 to 48.50
• 52-Week Range: 37 to 62.25
• Volume: 570,415 shs
• Average Volume: 237,426 shs
• Market Capitalization: £41.18 million
• P/E Ratio: N/A
• Dividend Yield: 2.00%
• Price Target: GBX 60
• Consensus Rating: Buy

INSPECS Group Stock Analysis - MarketRank™

INSPECS Group scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

INSPECS Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

INSPECS Group has a consensus price target of GBX 60, representing about 48.1% upside from its current price of GBX 40.50.

Amount of Analyst Coverage

INSPECS Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of INSPECS Group is -894.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of INSPECS Group is -894.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

INSPECS Group has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SPEC.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

INSPECS Group pays a meaningful dividend of 2.00%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

INSPECS Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for SPEC.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.11

News Sentiment

INSPECS Group has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for INSPECS Group this week, compared to 0 articles on an average week.

Search Interest

2 people have searched for SPEC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, INSPECS Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.62% of the stock of INSPECS Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 26.98% of the stock of INSPECS Group is held by institutions.

SPEC Stock Analysis - Frequently Asked Questions

How have SPEC shares performed this year?

INSPECS Group's stock was trading at GBX 45.10 at the start of the year. Since then, SPEC shares have decreased by 10.2% and is now trading at GBX 40.50.

How were INSPECS Group's earnings last quarter?

INSPECS Group plc (LON:SPEC) released its earnings results on Thursday, September, 18th. The company reported $2.19 earnings per share for the quarter. INSPECS Group had a negative net margin of 2.10% and a negative trailing twelve-month return on equity of 4.00%.

How do I buy shares of INSPECS Group?

Shares of SPEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of INSPECS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that INSPECS Group investors own include ConvaTec Group (CTEC), Guild Esports (GILD), Trifast (TRI), Allied Gaming & Entertainment (AGAE), C3.ai (AI), Avino Silver & Gold Mines (ASM) and Academy Sports and Outdoors (ASO).

Company Calendar

• Last Earnings: 9/18/2025
• Today: 9/20/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: LON:SPEC
• CIK: N/A
• Web: inspecs.com
• Phone: 44 1125 717 000
• Fax: N/A
• Employees: 1,673
• Year Founded: N/A

Price Target and Rating

• Average Price Target for INSPECS Group: GBX 60
• High Price Target: GBX 60
• Low Price Target: GBX 60
• Potential Upside/Downside: +48.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX (0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.30
• P/E Growth: N/A
• Net Income: -£4.11 million
• Net Margins: -2.10%
• Pretax Margin: N/A
• Return on Equity: -4.00%
• Return on Assets: 0.45%

Debt

• Debt-to-Equity Ratio: 43.59
• Current Ratio: 1.46
• Quick Ratio: 0.89

Sales & Book Value

• Annual Sales: £195.28 million
• Price / Sales: 0.21
• Cash Flow: GBX 24.88 per share
• Price / Cash Flow: 1.63
• Book Value: GBX 100.26 per share
• Price / Book: 0.40

Miscellaneous

• Outstanding Shares: 101,672,000
• Free Float: N/A
• Market Cap: £41.18 million
• Optionable: Not Optionable
• Beta: 2.22